Balchem Corporation (BCPC)

Acerca de Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Al 3 de noviembre de 2026, la acción de Balchem Corporation (BCPC) avanzó ligeramente a $174.89, un alza de 0.17% (+$0.29) frente al cierre anterior. En la sesión, las acciones han operado entre $172.56 y $175.32. Eso ubica a BCPC en el tercio superior de su rango de 52 semanas, de $147.18 a $183.90. Balchem Corporation opera en el sector de chemicals & allied products y tiene una capitalización de mercado de aproximadamente $5.42 mil millones, con cerca de 33.4 mil acciones negociadas.

Últimas noticias de BCPC

• Balchem Corporation to Participate in Baird’s Global Industrial Conference on November 11, 2026Yahoo Finance· 28 oct, 7:00 a.m. ET
• 3 Companies With Room to Pass on Costs to Manage Inflationmarketbeat.com· 26 oct, 11:30 a.m. ET
• Balchem (BCPC) Stock Can Q3 Earnings Spark A Bigger Rerating?Yahoo Finance· 25 oct, 5:11 a.m. ET
• Balchem Corporation Q3 2026 Earnings Call Summaryapp.moby.co· 24 oct, 8:30 a.m. ET
• Balchem: 3 Key Takeaways for Long-Term Investorsfool.com· 23 oct, 2:32 p.m. ET
• Balchem (BCPC) Q3 2026 Earnings Call Transcriptfool.com· 23 oct, 2:13 p.m. ET
• Balchem Corporation Reports Third Quarter 2026 Financial ResultsYahoo Finance· 23 oct, 7:00 a.m. ET
• Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026Yahoo Finance· 9 oct, 7:00 a.m. ETET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de BCPC en un solo lugar? Crea una cuenta gratis →

• New research on @BalchemCorp $BCPC #sidotiresearch Read note: http://dlvr.it/TW90wc #investing #smallcap #microcap

  @Sidoti· 2 nov, 2:48 p.m. ET

• $BCPC Balchem's record Q3 held a $4.0M legal gain, partly offset by a $1.9M impairment, as Human Nutrition & Health prices fell 4.4%. 🏢 Balchem, a nutrition ingredients and specialty products maker worth about $5.56B at $174.325 at 10:31 ET on October 26, 2026, said i…

  @filecrux· 26 oct, 10:35 a.m. ET

• https://www.marketbeat.com/earnings/reports/2026-10-23-balchem-co-stock/ $BCPC Balchem Earnings Transcript

  @EarningsInsider· 23 oct, 12:01 p.m. ET

• $BCPC Balchem Q3 sales hit a record 290.7 million dollars, up 8.6%, and adjusted EPS was 1.57 dollars vs 1.43 dollars expected (MarketBeat). All three segments grew. Human nutrition was still the engine, record sales of 188.2 million dollars, up 8.1%, with segment earnings up …

  @KryptonResearch14· 23 oct, 9:31 a.m. ET

• $BCPC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.57 up 16.30% YoY • Reported revenue of $290.66M up 8.63% YoY

  @StocktwitsEarnings· 23 oct, 7:29 a.m. ET

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →